The Drug-Induced Respiratory Disease Website and App

Corticosteroids, systemic (oral, parenteral)

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LI.x

Hypertrophic cardiomyopathy

Publications

Röhr SB, Sauer H, Gottschling S, Abdul-Khaliq H, Gortner L, Nunold H, Gräber S, Meyer S

Non-neurological, steroid-related adverse events in very low birth weight infants: a prospective audit.

Swiss medical weekly 2014;144;w13954 — 2014 — w13954

Bassareo PP, Abella R, Fanos V, Mercuro G

Biomarkers of corticosteroid-induced hypertrophic cardiomyopathy in preterm babies.

Frontiers in bioscience (Elite edition) 2010 Jun 01;2;1460-71 — 2010 Jun 01 — 1460-71

Vimala J, Prabhu A, Pavithran S, Kumar RN

Hydrocortisone induced hypertrophic cardiomyopathy.

International journal of cardiology 2011 Aug 04;150;e94-5 — 2011 Aug 04 — e94-5

Boeuf B, Maragnes P, Belzic I, Lacotte J, Bonte JB, Guillois B

[Glucocorticoid-induced hypertrophic cardiomyopathy in premature infants: apropos of 4 cases].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 1997 Feb;4;152-7 — 1997 Feb — 152-7

Gill AW, Warner G, Bull L

Iatrogenic neonatal hypertrophic cardiomyopathy.

Pediatric cardiology 1996 Sep-Oct;17;335-9 — 1996 Sep-Oct — 335-9